This ability to alter transporter activity and expression explains how Api, despite its simple structure, effectively enhances the intracellular accumulation of drugs, improving the efficacy of treatments that are commonly pumped out by ABC transporters in resistant cancer cells [18]. The gene discussed is SERPINF2; the disease is cancer.